Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

Empagliflozin favorably reshaped left ventricles in HFrEF patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 15, 2020
News
GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 13, 2020
News
New eGFR equation ‘less biased’ by age, kidney function; some disagree
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 10, 2020
News

No link shown between thyroid dysfunction and heart failure
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 10, 2020
News
MADIT-CRT: Resynchronization linked to fewer heart failure hospitalizations
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 3, 2020
News
Novel drug slows progression of diabetic kidney disease
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 29, 2020
News

Experts tout immediate quadruple therapy for HFrEF patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 20, 2020
News
Entresto halves renal events in preserved EF heart failure patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 15, 2020
News

T2D treatments create tension between glycemic and cardiovascular goals
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 12, 2020
News

Adrenal vein sampling looms as choke point for aldosteronism assessment of hypertensives
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 12, 2020
News

Empagliflozin cut PA pressures in heart failure patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 12, 2020
News

EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 6, 2020
News

Music’s charms may soothe heart failure’s effects
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 5, 2020
News

Dapagliflozin’s CKD performance sends heart failure messages
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 5, 2020
News

New data challenge primary care’s inattention to aldosterone in hypertension
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 1, 2020